Rolled over 2 years since this 'near production' asset was acquired. Id like to see some stats on whether any 'near term production' acquisitions have ever gone anywhere. I am guessing not.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025